ANI Pharma

ANIP NASDAQ
81.31
+0.56
+0.69%
Opening 15:01 07/22 EDT
Open
80.97
Prev Close
80.75
High
81.80
Low
80.25
Volume
58.11K
Avg Vol (3M)
144.63K
52 Week High
84.10
52 Week Low
36.92
% Turnover
0.48%
Market Cap
979.60M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ANI Pharma ANIP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.
MORE >

Recently

Name
Price
%Change